Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Anticoagulant Injections Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
  • 1.2.2 LMWH
  • 1.2.3 Unfractionated Heparin
  • 1.2.4 Fibrinolytics
  • 1.2.5 Other
• 1.3 Market by Application
  • 1.3.1 Global Anticoagulant Injections Market Share by Application: 2017 VS 2021 VS 2028
  • 1.3.2 VTE
  • 1.3.3 ACS/MI
  • 1.3.4 AF
  • 1.3.5 Other
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Anticoagulant Injections Market Perspective (2017-2028)
• 2.2 Anticoagulant Injections Growth Trends by Region
  • 2.2.1 Anticoagulant Injections Market Size by Region: 2017 VS 2021 VS 2028
  • 2.2.2 Anticoagulant Injections Historic Market Size by Region (2017-2022)
  • 2.2.3 Anticoagulant Injections Forecasted Market Size by Region (2023-2028)
• 2.3 Anticoagulant Injections Market Dynamics
  • 2.3.1 Anticoagulant Injections Industry Trends
  • 2.3.2 Anticoagulant Injections Market Drivers
  • 2.3.3 Anticoagulant Injections Market Challenges
  • 2.3.4 Anticoagulant Injections Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Anticoagulant Injections Players by Revenue
  • 3.1.1 Global Top Anticoagulant Injections Players by Revenue (2017-2022)
  • 3.1.2 Global Anticoagulant Injections Revenue Market Share by Players (2017-2022)
• 3.2 Global Anticoagulant Injections Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Players Covered: Ranking by Anticoagulant Injections Revenue
• 3.4 Global Anticoagulant Injections Market Concentration Ratio
  • 3.4.1 Global Anticoagulant Injections Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Anticoagulant Injections Revenue in 2021
• 3.5 Anticoagulant Injections Key Players Head office and Area Served
• 3.6 Key Players Anticoagulant Injections Product Solution and Service
• 3.7 Date of Enter into Anticoagulant Injections Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Anticoagulant Injections Breakdown Data by Type

• 4.1 Global Anticoagulant Injections Historic Market Size by Type (2017-2022)
• 4.2 Global Anticoagulant Injections Forecasted Market Size by Type (2023-2028)

5 Anticoagulant Injections Breakdown Data by Application

• 5.1 Global Anticoagulant Injections Historic Market Size by Application (2017-2022)
• 5.2 Global Anticoagulant Injections Forecasted Market Size by Application (2023-2028)

6 North America

• 6.1 North America Anticoagulant Injections Market Size (2017-2028)
• 6.2 North America Anticoagulant Injections Market Size by Country (2017-2022)
• 6.3 North America Anticoagulant Injections Market Size by Country (2023-2028)
• 6.4 United States
• 6.5 Canada

7 Europe

• 7.1 Europe Anticoagulant Injections Market Size (2017-2028)
• 7.2 Europe Anticoagulant Injections Market Size by Country (2017-2022)
• 7.3 Europe Anticoagulant Injections Market Size by Country (2023-2028)
• 7.4 Germany
• 7.5 France
• 7.6 U.K.
• 7.7 Italy
• 7.8 Russia
• 7.9 Nordic Countries

8 Asia-Pacific

• 8.1 Asia-Pacific Anticoagulant Injections Market Size (2017-2028)
• 8.2 Asia-Pacific Anticoagulant Injections Market Size by Country (2017-2022)
• 8.3 Asia-Pacific Anticoagulant Injections Market Size by Country (2023-2028)
• 8.4 China
• 8.5 Japan
• 8.6 South Korea
• 8.7 Southeast Asia
• 8.8 India
• 8.9 Australia

9 Latin America

• 9.1 Latin America Anticoagulant Injections Market Size (2017-2028)
• 9.2 Latin America Anticoagulant Injections Market Size by Country (2017-2022)
• 9.3 Latin America Anticoagulant Injections Market Size by Country (2023-2028)
• 9.4 Mexico
• 9.5 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Anticoagulant Injections Market Size (2017-2028)
• 10.2 Middle East & Africa Anticoagulant Injections Market Size by Country (2017-2022)
• 10.3 Middle East & Africa Anticoagulant Injections Market Size by Country (2023-2028)
• 10.4 Turkey
• 10.5 Saudi Arabia
• 10.6 UAE

11 Key Players Profiles

• 11.1 Sanofi
  • 11.1.1 Sanofi Company Detail
  • 11.1.2 Sanofi Business Overview
  • 11.1.3 Sanofi Anticoagulant Injections Introduction
  • 11.1.4 Sanofi Revenue in Anticoagulant Injections Business (2017-2022)
  • 11.1.5 Sanofi Recent Development
• 11.2 Genentech (Roche)
  • 11.2.1 Genentech (Roche) Company Detail
  • 11.2.2 Genentech (Roche) Business Overview
  • 11.2.3 Genentech (Roche) Anticoagulant Injections Introduction
  • 11.2.4 Genentech (Roche) Revenue in Anticoagulant Injections Business (2017-2022)
  • 11.2.5 Genentech (Roche) Recent Development
• 11.3 Boehringer Ingelheim
  • 11.3.1 Boehringer Ingelheim Company Detail
  • 11.3.2 Boehringer Ingelheim Business Overview
  • 11.3.3 Boehringer Ingelheim Anticoagulant Injections Introduction
  • 11.3.4 Boehringer Ingelheim Revenue in Anticoagulant Injections Business (2017-2022)
  • 11.3.5 Boehringer Ingelheim Recent Development
• 11.4 Aspen
  • 11.4.1 Aspen Company Detail
  • 11.4.2 Aspen Business Overview
  • 11.4.3 Aspen Anticoagulant Injections Introduction
  • 11.4.4 Aspen Revenue in Anticoagulant Injections Business (2017-2022)
  • 11.4.5 Aspen Recent Development
• 11.5 Pfizer
  • 11.5.1 Pfizer Company Detail
  • 11.5.2 Pfizer Business Overview
  • 11.5.3 Pfizer Anticoagulant Injections Introduction
  • 11.5.4 Pfizer Revenue in Anticoagulant Injections Business (2017-2022)
  • 11.5.5 Pfizer Recent Development
• 11.6 Hepalink
  • 11.6.1 Hepalink Company Detail
  • 11.6.2 Hepalink Business Overview
  • 11.6.3 Hepalink Anticoagulant Injections Introduction
  • 11.6.4 Hepalink Revenue in Anticoagulant Injections Business (2017-2022)
  • 11.6.5 Hepalink Recent Development
• 11.7 King-friend
  • 11.7.1 King-friend Company Detail
  • 11.7.2 King-friend Business Overview
  • 11.7.3 King-friend Anticoagulant Injections Introduction
  • 11.7.4 King-friend Revenue in Anticoagulant Injections Business (2017-2022)
  • 11.7.5 King-friend Recent Development
• 11.8 CSBIO
  • 11.8.1 CSBIO Company Detail
  • 11.8.2 CSBIO Business Overview
  • 11.8.3 CSBIO Anticoagulant Injections Introduction
  • 11.8.4 CSBIO Revenue in Anticoagulant Injections Business (2017-2022)
  • 11.8.5 CSBIO Recent Development
• 11.9 Amphastar Pharmaceuticals
  • 11.9.1 Amphastar Pharmaceuticals Company Detail
  • 11.9.2 Amphastar Pharmaceuticals Business Overview
  • 11.9.3 Amphastar Pharmaceuticals Anticoagulant Injections Introduction
  • 11.9.4 Amphastar Pharmaceuticals Revenue in Anticoagulant Injections Business (2017-2022)
  • 11.9.5 Amphastar Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer

Summary:

Industry Insights
The global Anticoagulant Injections market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, LMWH accounting for % of the Anticoagulant Injections global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While VTE segment is altered to an % CAGR throughout this forecast period.
China Anticoagulant Injections market size is valued at US$ million in 2021, while the North America and Europe Anticoagulant Injections are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Anticoagulant Injections landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Anticoagulant Injections market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Anticoagulant Injections market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Anticoagulant Injections market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Anticoagulant Injections market.
Impact of Covid-19 Outbreak
This section of the report has explored the overall status of the Covid scenario and has offered valuable insights into the changes in supply chain disruption, fluctuations in demand, etc. The analysts have also focused on the key measures that the companies are opting to withstand the harsh scenario.
Segmental Analysis
The report has been segmented into product and application segments. The researchers have documented all the products present today in the Anticoagulant Injections market. They have also shed light on the new product innovations and launches by the key players. In the segmental analysis, the analysts have provided revenue forecast figures based on type and application for the period 2017-2028. They have also discussed about the growth rate and potential of each segment for the period 2017-2028.
Anticoagulant Injections Breakdown Data by Type
LMWH
Unfractionated Heparin
Fibrinolytics
Other
Anticoagulant Injections Breakdown Data by Application
VTE
ACS/MI
AF
Other
Regional Analysis
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Competitive Landscape
This segment focuses on the key players operating in the industry. It underlines all the current and future activities by the prominent manufacturers. By understanding various initiatives being taken up by different players, readers will gain the ability to settle on correct business choices. The authors of the report have provided accurate revenue figures of the companies for the period 2017-2022. The clients are sure to gain the upper hand once they get hold of this report. Key players studied in the research report include:
Sanofi
Genentech (Roche)
Boehringer Ingelheim
Aspen
Pfizer
Hepalink
King-friend
CSBIO
Amphastar Pharmaceuticals
Frequently Asked Questions
What factors will challenge the Anticoagulant Injections market growth?
Which end-use segment will expand at the fastest CAGR in the Anticoagulant Injections market?
Which are the emerging players in the Anticoagulant Injections market?
How concentrated is the Anticoagulant Injections market?
Which factors are positively contributing to the Anticoagulant Injections market growth?
Which are the novel product innovations in the Anticoagulant Injections market?
Which product segment will emerge as the most lucrative in the Anticoagulant Injections market?
Which factors are increasing the competition in the Anticoagulant Injections market?
Which are the strategic measures taken by the Anticoagulant Injections industry players?
Which region will witness inactive growth during the forecast period?
What key trends are likely to emerge in the Anticoagulant Injections market in the coming years?